What are the short-term benefits and potential harms of therapeutic modalities for the management of overactive bladder syndrome in women? A review of evidence …

F Farag, VI Sakalis, SM Arteaga, N Sihra… - European Urology, 2023 - Elsevier
Context Overactive bladder syndrome (OAB) is highly prevalent among women and has a
negative impact on their quality of life. The current available treatments for OAB symptoms …

Anticholinergic drugs versus non‐drug active therapies for overactive bladder syndrome in adults

AA Alhasso, J McKinlay, K Patrick… - Cochrane Database of …, 2006 - cochranelibrary.com
Background Overactive Bladder Syndrome (OAB) is defined as urgency, with or without
urgency incontinence, usually with frequency and nocturia. Pharmacotherapy with …

[PDF][PDF] The pharmacological treatment of urinary incontinence

KE Andersson, R Appell, LD Cardozo, C Chapple… - BJU …, 1999 - academia.edu
The pharmacological treatment of urinary incontinence Page 1 BJU International (1999), 84,
923–947 REVIEW The pharmacological treatment of urinary incontinence K.-E …

Drug delivery approaches for managing overactive bladder (OAB): a systematic review

Z Khizer, A Sadia, R Sharma, S Farhaj, JS Nirwan… - Pharmaceuticals, 2021 - mdpi.com
Overactive bladder syndrome (OAB) is characterised by urgency symptoms, with or without
urgency incontinence, usually with frequency and nocturia and severely affects the quality of …

Outcome measures for urinary incontinence

JG Blaivas - Urology, 1998 - Elsevier
Objectives. To discuss the rudiments of data that need to be collected in order to develop
validated reproducible, well-accepted efficacy instruments for assessing treatment outcomes …

[HTML][HTML] The challenge of overactive bladder therapy: alternative to antimuscarinic agents

M Lazzeri, M Spinelli - International braz j urol, 2006 - SciELO Brasil
Contemporary, the management of overactive bladder (OAB), a medical condition
characterized by urgency, with or without urge urinary incontinence, frequency and nocturia …

Pharmacologic causes of female incontinence

AC Steele, N Kohli, P Mallipeddi, M Karram - International Urogynecology …, 1999 - Springer
The etiology of female urinary incontinence is complex and multifactorial. Many medications
have adverse effects on the lower urinary tract, including the promotion of incontinence in …

New pharmacologic targets for the treatment of the overactive bladder: an update

KE Andersson - Urology, 2004 - Elsevier
Although currently available antimuscarinic agents are the standard of care for overactive
bladder (OAB), they are limited by certain side effects, particularly dry mouth and …

Diagnosis and treatment of the overactive bladder

AJ Wein - Urology, 2003 - Elsevier
Overactive bladder syndrome (OAB) is a symptomatic diagnosis based on the presence of
urgency, with or without urge incontinence, and usually accompanied by frequency and …

Treatment of overactive bladder: other drug mechanisms

KE Andersson - Urology, 2000 - Elsevier
The well-known side effects of antimuscarinic drugs have focused interest on other ways of
treating overactive bladder. Targets for pharmacologic intervention may be found in the …